EUVIMEDEUVIMED entdecken
Crossref

A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease

Wei Liu, Yuqiang Wang, Moussa B. H. Youdim

Ageing and Neurodegenerative Diseases · 2022

DOI: 10.20517/and.2021.09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ageing and Neurodegenerative Diseases, 2022. Verfasst von Wei Liu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Gefördert von: Youdim Pharmaceuticals.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current novel therapeutic approach suggests that multi-targeted compounds, with diverse biological activities but a single set of bioavailability and pharmacokinetics, will be significantly more advantageous in the treatment of the complex pathology of Parkinson’s diseases (PD) than traditional therapies. This review introduces a novel cholinesterase (ChE)-monoamine oxidase (MAO) inhibitor, namely MT-031, which was designed by amalgamating the propargyl moiety of the irreversible selective MAO-B inhibitor and neuroprotective/neurorestorative anti-Parkinsonian drug, rasagiline, into the methylamino position of the ChE inhibitor anti-AD drug, rivastigmine. MT-031 possesses neuroprotective, cognition enhancing, anti-depressant, and anti-inflammatory properties both in vitro and in vivo. Altogether, these findings suggest that MT-031 may be a potential treatment for combating PD and associated dementia and depression.

Förderung

  • Youdim Pharmaceuticals

Zitieren

APA

Liu, W., Wang, Y., & Youdim, M. B. H. (2022). A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease. Ageing and Neurodegenerative Diseases. https://doi.org/10.20517/and.2021.09

Vancouver

Liu W, Wang Y, Youdim MBH. A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease. Ageing and Neurodegenerative Diseases. 2022. doi:10.20517/and.2021.09

BibTeX
@article{Liu2022,
  author = {Liu, Wei and Wang, Yuqiang and Youdim, Moussa B. H.},
  title = {A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease},
  journal = {Ageing and Neurodegenerative Diseases},
  year = {2022},
  doi = {10.20517/and.2021.09}
}
Kostenlos starten →